Development and characterization of inhaled ethanol as a novel pharmacological strategy currently evaluated in a phase ii clinical trial for early-stage sars-cov-2 infection
Autores
Castro-Balado, A., Mondelo-García, C., Barbosa-Pereira, L., Varela-Rey, I., Novo-Veleiro, I., Vázquez-Agra, N., Antúnez-López, J. R., Bandín-Vilar, E. J., Sendón-García, R., Busto-Iglesias, M., de Quirós, A. R.-B., García-Quintanilla, L., González-Barcia,
Año de publicación
2021
Publicado en
Pharmaceutics, 13(3)
